Statement Regarding Rotarix and RotaTeq Rotavirus Vaccines and Intussusception
This statement summarizes several post-licensure evaluations on rotavirus vaccines and intussusception that were presented to the US Advisory Committee on Immunization Practices. Some studies performed outside the United States have detected a low-level increased risk of intussusception following rotavirus vaccination, particularly shortly after the first dose. The level of risk observed in these post-marketing studies is substantially lower than the risk of intussusception after vaccination with RotaShield®, the previous rotavirus vaccine.
Author(s): US Centers for Disease Control and Prevention
Visit web page (English)
(Located at www.cdc.gov)